Correction to: The attitude of fully vaccinated individuals towards COVID-19 vaccine booster dose: a transverse study from Jordan

IF 0.5 Q4 HEALTH CARE SCIENCES & SERVICES Journal of Pharmaceutical Health Services Research Pub Date : 2023-02-01 DOI:10.1093/jphsr/rmac047
S. Abuhammad, O. Khabour, Shaher Hamaideh
{"title":"Correction to: The attitude of fully vaccinated individuals towards COVID-19 vaccine booster dose: a transverse study from Jordan","authors":"S. Abuhammad, O. Khabour, Shaher Hamaideh","doi":"10.1093/jphsr/rmac047","DOIUrl":null,"url":null,"abstract":"Objectives COVID-19 vaccines are efficient against serious infections, and those initiated by the various variants. Many high- and middle-income countries have decided to offer third-dose boosters to ensure their populations remain protected against novel COVID-19 variants before additional waves of COVID-19. This study aims to assess individuals' attitudes towards COVID-19 booster vaccination dose and to determine predictors of this attitude. Methods This study used a cross-sectional descriptive design. The inclusion criteria for participants were Jordanian adults who had been fully vaccinated against COVID-19. A quota sampling strategy based on the participant's, age and gender was used to ensure that the sample was broadly representative of the general population in Jordan. The instrument was distributed across popular social networking sites such as Facebook and WhatsApp. The study was conducted in October 2021. Key findings The response rate of this study was 63.5% (n = 952). The mean score of attitudes towards a booster dose of COVID-19 was 47.1 +/- 8.2, indicating that about half of the sample was supportive to the booster dose. There were differences in the acceptability of a booster dose for COVID-19 according to the demographic and clinical characteristics of the participants. Individuals with high income (B = 0.210, P = 0.000), high educational level (B = -0.076, P = 0.026), those who have suffered vaccine side effects (B = -0.081, P = 0.013) and follow the news about COVID-19 (B = 0.076, P = 0.043) were more likely to accept the booster dose than the other groups. Conclusions Participants had mixed attitudes towards the booster dose with about half of the participants willing to take the booster. Some factors associated with such attitude were identified. The findings are useful in developing and implementing effective vaccination strategies that target people who are not ready to take a booster dose.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Health Services Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jphsr/rmac047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives COVID-19 vaccines are efficient against serious infections, and those initiated by the various variants. Many high- and middle-income countries have decided to offer third-dose boosters to ensure their populations remain protected against novel COVID-19 variants before additional waves of COVID-19. This study aims to assess individuals' attitudes towards COVID-19 booster vaccination dose and to determine predictors of this attitude. Methods This study used a cross-sectional descriptive design. The inclusion criteria for participants were Jordanian adults who had been fully vaccinated against COVID-19. A quota sampling strategy based on the participant's, age and gender was used to ensure that the sample was broadly representative of the general population in Jordan. The instrument was distributed across popular social networking sites such as Facebook and WhatsApp. The study was conducted in October 2021. Key findings The response rate of this study was 63.5% (n = 952). The mean score of attitudes towards a booster dose of COVID-19 was 47.1 +/- 8.2, indicating that about half of the sample was supportive to the booster dose. There were differences in the acceptability of a booster dose for COVID-19 according to the demographic and clinical characteristics of the participants. Individuals with high income (B = 0.210, P = 0.000), high educational level (B = -0.076, P = 0.026), those who have suffered vaccine side effects (B = -0.081, P = 0.013) and follow the news about COVID-19 (B = 0.076, P = 0.043) were more likely to accept the booster dose than the other groups. Conclusions Participants had mixed attitudes towards the booster dose with about half of the participants willing to take the booster. Some factors associated with such attitude were identified. The findings are useful in developing and implementing effective vaccination strategies that target people who are not ready to take a booster dose.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
更正:完全接种疫苗的个人对新冠肺炎疫苗加强剂的态度:来自约旦的横向研究
目的新冠肺炎疫苗对严重感染和各种变异引起的感染有效。许多高收入和中等收入国家已决定提供第三剂加强针,以确保其人口在新一波新冠肺炎之前免受新的新冠肺炎变种的感染。本研究旨在评估个人对新冠肺炎加强针接种剂量的态度,并确定这种态度的预测因素。方法采用横断面描述性设计。参与者的入选标准是已完全接种新冠肺炎疫苗的约旦成年人。采用了基于参与者、年龄和性别的配额抽样策略,以确保样本广泛代表约旦的普通人口。该仪器分布在Facebook和WhatsApp等流行的社交网站上。该研究于2021年10月进行。主要发现本研究的有效率为63.5%(n=952)。对新冠肺炎加强剂量的态度平均得分为47.1+/-8.2,表明约一半的样本支持加强剂量。根据参与者的人口统计学和临床特征,新冠肺炎加强剂量的可接受性存在差异。与其他群体相比,高收入(B=0.210,P=0.000)、高教育水平(B=-0.076,P=0.026)、疫苗副作用(B=0.0181,P=0.013)和关注新冠肺炎新闻(B=0.076,P=0.043)的个体更可能接受加强针。结论参与者对加强剂量的态度不一,大约一半的参与者愿意服用加强剂量。确定了与这种态度相关的一些因素。这些发现有助于制定和实施针对尚未准备好接种加强针的人群的有效疫苗接种策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Pharmaceutical Health Services Research
Journal of Pharmaceutical Health Services Research HEALTH CARE SCIENCES & SERVICES-
CiteScore
1.50
自引率
0.00%
发文量
45
期刊最新文献
The revised patient attitudes to deprescribing (rPATD) questionnaire: an investigation using a large anonymized database Evaluation of a structured pharmacist-led intervention on glycemic control in underprivileged diabetic patients: a randomized open-label trial Cross-sectional study of pharmacists’ knowledge and beliefs about human papillomavirus, its vaccines, and barriers related to vaccine administration Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021 Navigating digital health: perspectives of Australian community pharmacists—a short communication
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1